By Karlee Weinmann ( March 19, 2012, 8:19 PM EDT) -- The U.S. Food and Drug Administration on Monday approved the first generic versions of the popular osteoporosis drug Boniva, opening the door to generic-drug makers Mylan Pharmaceuticals Inc., Apotex Inc. and Orchid Healthcare to compete with F. Hoffman-La Roche Ltd.'s blockbuster treatment. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.